Is Biogen cutting costs due to Aduhelm struggles?

Hey everyone. Seeing a lot of chatter and some weird energy around the place lately. Aduhelm's price drop is obviously a huge deal, and while it's not officially stated, it feels like they're preparing for something. I've heard whispers from a couple of different teams about projects being shelved unexpectedly, and some PIs seem a lot more stressed than usual. Anyone else getting this vibe? Feels like a pretty significant cost-cutting measure is brewing, and layoffs would be the obvious next step if they're trying to salvage the financials. Just trying to get a pulse check from others here. Trying not to panic, but it's hard not to read the tea leaves when things feel this uncertain.